GO:0050852 T cell receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050852 (T cell receptor signaling pathway) describes the molecular signal cascade triggered when the T cell receptor (TCR) is cross-linked by antigen.
• TCR signal transduction depends on the CD3 complex, co-receptors CD4/CD8, and Src-family kinases Lck and Fyn that phosphorylate ITAM motifs.
• Liquid-liquid phase separation of signaling molecules such as LAT and Grb2 enhances TCR sensitivity and amplifies downstream signaling.
• Dysregulated TCR signaling is central to T-cell lymphomas, autoimmune diseases, and impaired antitumor immunity.
• Co-receptors and post-translational modifiers such as DHHC21 palmitoyltransferase fine-tune TCR signaling strength and duration.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of TCR pathway genes.
Description
The T cell receptor (TCR) signaling pathway (GO:0050852) is the biological process initiated by cross-linking of the antigen receptor on a T cell, converting extracellular antigen recognition into intracellular signals that drive T cell activation, proliferation, and effector function. This pathway is fundamental to adaptive immunity and is a major focus of research in immunology, oncology, and autoimmune disease. Understanding its molecular choreography has been accelerated by advances in single-molecule imaging, phase-separation biology, and CRISPR-based genetic screens. Because TCR signaling is a central growth regulatory pathway, its alterations are recurrently observed in peripheral T-cell lymphoma and other hematologic malignancies. Moreover, modulation of TCR signaling by co-receptors and microbial metabolites influences responses to immune checkpoint blockade, making this pathway a therapeutic target. Researchers studying GO:0050852 need robust experimental models to determine how individual genes contribute to signal initiation, propagation, and termination.
T cell receptor signaling pathway At A Glance
| GO ID | GO:0050852 |
|---|---|
| GO term | T cell receptor signaling pathway |
| Ontology | biological_process |
| Synonym | T-cell receptor signaling pathway; TCR signaling pathway; T lymphocyte receptor signaling pathway |
| Major function | Transduces antigen recognition into intracellular signals that activate T cells |
| Key initiator | Cross-linking of the T cell receptor by peptide-MHC complexes |
| Major kinases | Lck, Fyn, ZAP-70, and downstream MAPK/NF-kB/PI3K effectors |
| Cellular context | T lymphocytes, including CD4+ helper and CD8+ cytotoxic T cells |
What Is GO:0050852?
According to the Gene Ontology, GO:0050852 (T cell receptor signaling pathway) is defined as the series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. In other words, it encompasses all molecular events that begin when a TCR binds its cognate antigen-MHC ligand and transmit signals into the cell, leading to changes in gene expression, metabolism, and cell fate.
Why Is T cell receptor signaling pathway Important in Cell Biology?
GO:0050852 is essential for adaptive immunity, as it governs T cell activation, differentiation, and effector responses. Defects in TCR signaling cause immunodeficiency, while hyperactivation contributes to autoimmunity and T-cell malignancies. The pathway also determines the efficacy of cancer immunotherapies, including anti-PD-1 blockade, and is modulated by co-receptors and metabolic signals. Therefore, precise experimental dissection of TCR signaling is critical for understanding disease mechanisms and developing targeted interventions.
• Controls T cell activation and adaptive immune responses.
• Mutations in TCR signaling components cause immunodeficiencies and autoimmunity.
• Altered TCR signaling is a hallmark of peripheral T-cell lymphoma.
• Modulates response to immune checkpoint inhibitors such as anti-PD-1.
• Co-receptors CD4/CD8 and CD28 shape signaling thresholds and are therapeutic targets.
• Phase separation of LAT and Grb2 amplifies TCR sensitivity.
• Palmitoylation by DHHC21 regulates TCR signaling strength.
• TCR signaling is a central growth regulatory pathway in T cells.
• Single-molecule studies reveal proofreading and sensitivity mechanisms.
• CRISPR screens identify novel regulators of TCR signaling.
What Happens During T cell receptor signaling pathway?
Antigen recognition and receptor cross-linking
In simple terms: The TCR binds antigen and gets clustered together, which starts the signal.
The pathway begins when the T cell receptor (TCR) binds a peptide-MHC complex presented by an antigen-presenting cell, leading to cross-linking of multiple TCRs. This clustering brings the CD3 complex and associated ITAM motifs into proximity with Src-family kinases, primarily Lck, which phosphorylate ITAM tyrosines.
ITAM phosphorylation and ZAP-70 recruitment
In simple terms: Phosphorylated ITAMs act as docking sites for ZAP-70, a key kinase.
Phosphorylated ITAMs on CD3 chains recruit ZAP-70 via its tandem SH2 domains. Lck then phosphorylates and activates ZAP-70, which in turn phosphorylates adaptor proteins such as LAT and SLP-76. This step is critical for propagating the signal from the receptor to downstream pathways.
Formation of the LAT signalosome and phase separation
In simple terms: Signaling proteins condense into droplets, making the signal stronger and more sustained.
Phosphorylated LAT nucleates a signalosome by recruiting Grb2, Gads, PLC-gamma1, and PI3K. Recent studies show that LAT and Grb2 undergo liquid-liquid phase separation, forming condensates that enhance TCR signaling sensitivity and proofreading. This condensate formation is a key mechanism for amplifying weak antigen signals.
Downstream effector pathways: calcium, MAPK, and NF-kB
In simple terms: The signal splits into several routes that turn on genes for T cell activation.
The LAT signalosome activates PLC-gamma1, which generates IP3 and DAG, leading to calcium flux and PKC activation. This triggers the MAPK/ERK pathway, NF-kB activation, and NFAT nuclear translocation, collectively driving transcription of genes such as IL-2 and CD69. PI3K-Akt signaling also promotes survival and metabolism.
Co-receptor and co-stimulatory modulation
In simple terms: Helper molecules like CD4, CD8, and CD28 adjust the volume of the signal.
Co-receptors CD4 and CD8 bind MHC class II and class I, respectively, and recruit Lck to the TCR complex, lowering the threshold for activation. Co-stimulation through CD28 further amplifies signaling, while inhibitory receptors such as CTLA-4 and PD-1 attenuate it. These modulatory inputs determine the outcome of TCR engagement.
Signal termination and feedback regulation
In simple terms: The signal is switched off by phosphatases and degradation to prevent overactivation.
Termination involves phosphatases such as SHP-1 and SHIP-1, ubiquitin-mediated degradation of signaling components, and endocytosis of the TCR. Feedback loops involving Cbl and Itch regulate the duration and intensity of signaling, which is essential for maintaining self-tolerance and preventing autoimmunity.
Key Genes Involved in GO:0050852 T cell receptor signaling pathway
The following genes encode core components and regulators of the T cell receptor signaling pathway (GO:0050852) that are frequently studied using CRISPR models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD3E | CD3 epsilon chain, ITAM-bearing signaling subunit of TCR complex | Knockout causes severe immunodeficiency; target for functional studies |
| LCK | Src-family kinase that phosphorylates ITAMs and ZAP-70 | Essential for TCR signaling initiation; KO blocks T cell development |
| ZAP70 | Syk-family kinase recruited to phosphorylated ITAMs | Mutations cause immunodeficiency; key node for signal propagation |
| LAT | Transmembrane adaptor that nucleates signalosome | Phase separation studies; KO abolishes downstream signaling |
| LCP2 | SLP-76 adaptor linking LAT to actin and calcium pathways | KO impairs T cell activation and thymocyte development |
| PLCG1 | Phospholipase C gamma 1, generates IP3 and DAG | Critical for calcium flux and MAPK activation |
| PIK3CD | PI3K catalytic subunit p110 delta | Regulates Akt signaling and T cell metabolism |
| GRB2 | Adaptor protein binding LAT and SOS | Phase separation component; modulates Ras-MAPK pathway |
| CD4 | Co-receptor for MHC class II, recruits Lck | Determines helper T cell activation threshold |
| CD8A | Co-receptor for MHC class I, recruits Lck | Essential for cytotoxic T cell responses |
| CD28 | Co-stimulatory receptor providing signal 2 | Target for immunotherapy; KO reduces T cell activation |
| PDCD1 | PD-1 inhibitory receptor | Checkpoint blockade target; regulates TCR signaling |
| DHHC21 | Palmitoyltransferase modifying signaling proteins | Regulates TCR signaling via acylation |
| PTPN6 | SHP-1 phosphatase, negative regulator | Terminates TCR signaling; KO causes hyperactivation |
| CBL | E3 ubiquitin ligase, downregulates TCR | Feedback inhibition; KO leads to autoimmunity |
| NFATC1 | Transcription factor downstream of calcium | Drives IL-2 expression; KO impairs T cell function |
| MAPK1 | ERK2 kinase in MAPK cascade | Links TCR to transcription; important for proliferation |
| IKBKB | IKK beta kinase activating NF-kB | Essential for T cell survival and effector function |
How Is T cell receptor signaling pathway Regulated?
TCR signaling is tightly regulated by multiple mechanisms. Protein acyltransferase DHHC21 mediates palmitoylation of signaling proteins, modulating their membrane localization and function. Co-receptors CD4 and CD8 regulate the threshold and kinetics of TCR signaling by recruiting Lck. Phase separation of LAT and Grb2 provides a physical mechanism for signal amplification and proofreading. Additionally, microbial metabolites such as butyrate can modulate TCR signaling in cytotoxic CD8 T cells, influencing anti-PD-1 efficacy. Negative feedback by phosphatases (SHP-1, SHIP-1) and ubiquitin ligases (Cbl) prevents excessive activation.
T cell receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ZAP70 | Immunodeficiency, autoimmunity | Knockout and point-mutation knock-in mice or cell lines |
| PLCG1 | Peripheral T-cell lymphoma | Overexpression and knockout in T cell lines |
| PDCD1 | Cancer immunotherapy response | Knockout in primary T cells for anti-PD-1 studies |
| DHHC21 | T cell signaling regulation | Knockout and overexpression to study palmitoylation |
| CD28 | Autoimmunity, lymphoma | Knock-in of mutant CD28 for signaling studies |
T-cell lymphoma and leukemia
Peripheral T-cell lymphoma (PTCL) frequently exhibits alterations in TCR signaling components, including mutations in PLCG1, CD28, and epigenetic regulators, leading to constitutive pathway activation that drives malignant growth. Targeting TCR signaling nodes is a therapeutic strategy in PTCL.
Autoimmunity and immunodeficiency
Loss-of-function mutations in TCR signaling genes such as ZAP70, LCK, or CD3 chains cause severe combined immunodeficiency, while gain-of-function variants or impaired negative regulation contribute to autoimmune diseases like lupus and rheumatoid arthritis. Understanding these mutations guides diagnosis and precision therapy.
Cancer immunotherapy response
The efficacy of immune checkpoint inhibitors, such as anti-PD-1 antibodies, depends on intact TCR signaling in cytotoxic CD8 T cells. Microbial metabolite butyrate enhances anti-PD-1 efficacy by modulating TCR signaling, highlighting the pathway as a biomarker and therapeutic target. Co-receptor modulation is also being explored for stroke treatment.
From T cell receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X initiate TCR signaling? | Knockout cell line (e.g., Jurkat) followed by TCR stimulation |
| Does a specific point mutation alter signaling? | Point-mutation knock-in via CRISPR |
| How does a fusion protein affect downstream pathways? | Knock-in of tagged or fusion construct |
| Does overexpression mimic oncogenic activation? | Overexpression cell model |
| What is the role of a gene in T cell development? | Knockout mouse or human iPSC-derived T cells |
| Can a gene be targeted for immunotherapy? | CRISPR library screening in primary T cells |
How to Study the T cell receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-proteomics | Phosphorylation of signaling proteins | Identify activated pathways after TCR stimulation |
| TIRF microscopy | TCR clustering and condensate dynamics | Study phase separation of LAT/Grb2 |
| CRISPR knockout screen | Gene essentiality for TCR signaling | Discover novel regulators |
| RNA-seq | Transcriptional changes | Measure activation-induced gene expression |
| Flow cytometry | Surface markers and cytokine production | Assess T cell activation status |
| Calcium imaging | Intracellular calcium flux | Monitor PLC-gamma1 activity |
| Immunoblotting | Protein phosphorylation and degradation | Validate specific signaling nodes |
| Proximity ligation assay | Protein-protein interactions | Detect signalosome assembly |
Phospho-proteomics and signaling profiling
Mass spectrometry-based phosphoproteomics can quantify changes in phosphorylation of TCR signaling components after stimulation, revealing pathway activation states and novel regulatory sites.
Live-cell imaging and single-molecule tracking
Total internal reflection fluorescence (TIRF) microscopy and single-molecule imaging visualize TCR clustering, LAT condensate formation, and signaling dynamics in real time.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout or activation screens in T cells identify positive and negative regulators of TCR signaling, as well as genes that modulate response to checkpoint blockade.
Transcriptomics and cytokine profiling
RNA-seq and cytokine bead arrays measure downstream transcriptional and secretory outputs of TCR signaling, such as IL-2, IFN-gamma, and CD69 expression.
How CRISPR Can Be Used to Study GO:0050852 T cell receptor signaling pathway
Knockout
CRISPR knockout of TCR signaling genes (e.g., LCK, ZAP70, LAT) in Jurkat or primary T cells abolishes or reduces pathway activation, providing causal evidence for gene function. Knockout models are also used to identify negative regulators such as PTPN6 and CBL.
Point Mutation
Point-mutation knock-in via CRISPR allows precise modeling of disease-associated variants (e.g., ZAP70 mutations) to study their impact on signaling and T cell development. This approach distinguishes loss-of-function from gain-of-function alleles.
Knock-in
Knock-in of tagged or fluorescently labeled signaling proteins (e.g., LAT-GFP) enables live-cell imaging of signalosome dynamics and phase separation. Knock-in of fusion proteins can also model oncogenic alterations seen in lymphoma.
Overexpression
Overexpression of wild-type or mutant TCR signaling genes (e.g., PLCG1, CD28) in T cell lines mimics constitutive activation and is used to study oncogenic potential and drug resistance. Overexpression models are valuable for screening targeted inhibitors.
How EDITGENE Supports T cell receptor signaling pathway Research
Researchers studying T cell receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in signal initiation, propagation, or termination. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that enable rigorous functional validation of TCR signaling components.
Contact EDITGENE today to design your custom CRISPR model for T cell receptor signaling pathway research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| Thy1 Knockout BV-2 Cell Line | EDJ-KQ07 | Mouse | 21838 | Details Get a Quote |
| PIK3CA Knockout Hep-G2 Cell Line | EDJ-KQ40 | Human | 5290 | Details Get a Quote |
| Thy1 Knockout LL/2 (LLC1) Cell Line | EDJ-KQ52 | Mouse | 21838 | Details Get a Quote |
| Thy1 Knockout RAW 264.7 Cell Line | EDJ-KQ62 | Mouse | 21838 | Details Get a Quote |
| Thy1 Knockout C2C12 Cell Line | EDJ-KQ81 | Mouse | 21838 | Details Get a Quote |
| Thy1 Knockout DC2.4 Cell Line | EDJ-KQ83 | Mouse | 21838 | Details Get a Quote |
| Thy1 Knockout Kupffer Cell Line | EDJ-KQ87 | Mouse | 21838 | Details Get a Quote |
| TRAF6 Knockout HEK293 Cell Line | EDJ-KQ107 | Human | 7189 | Details Get a Quote |
| MAP3K7 Knockout HEK293 Cell Line | EDJ-KQ142 | Human | 6885 | Details Get a Quote |
| IKBKG Knockout HEK293T Cell Line | EDJ-KQ207 | Human | 8517 | Details Get a Quote |
| PIK3CA Knockout HEK293 Cell Line | EDJ-KQ518 | Human | 5290 | Details Get a Quote |
| IKBKB Knockout HEK293 Cell Line | EDJ-KQ566 | Human | 3551 | Details Get a Quote |
| IKBKG Knockout HEK293 Cell Line | EDJ-KQ567 | Human | 8517 | Details Get a Quote |
| MALT1 Knockout HEK293 Cell Line | EDJ-KQ576 | Human | 10892 | Details Get a Quote |
| PLCG1 Knockout HEK293 Cell Line | EDJ-KQ582 | Human | 5335 | Details Get a Quote |
Displaying Records 1 To 15 Of 390 Records
- 1
- 2
- ...
- 24
- 25
- Next Page »
Frequently Asked Questions About T cell receptor signaling pathway
What is the T cell receptor signaling pathway?
It is the series of molecular signals initiated by cross-linking of the antigen receptor on a T cell, defined as GO:0050852.
What genes are involved in T cell receptor signaling pathway?
Key genes include CD3E, LCK, ZAP70, LAT, LCP2, PLCG1, CD4, CD8A, CD28, and PDCD1, among others.
What is the function of GO:0050852?
It transduces antigen recognition into intracellular signals that activate T cells, leading to proliferation, cytokine production, and effector function.
How is T cell receptor signaling regulated?
It is regulated by co-receptors, kinases, phosphatases, ubiquitin ligases, and phase separation of adaptors like LAT.
What diseases are associated with T cell receptor signaling defects?
Defects cause immunodeficiencies, autoimmunity, and T-cell lymphomas; the pathway also influences cancer immunotherapy response.
What methods are used to study T cell receptor signaling?
Common methods include phospho-proteomics, live-cell imaging, CRISPR screens, RNA-seq, and flow cytometry.
How can CRISPR help study T cell receptor signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal dissection of gene function in the pathway.
What is the role of phase separation in TCR signaling?
LAT and Grb2 form condensates that enhance sensitivity and proofreading of TCR signaling.
Which kinases are central to TCR signaling?
Lck, Fyn, and ZAP-70 are core kinases that initiate and propagate the signal.
How does butyrate affect TCR signaling?
Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating TCR signaling in cytotoxic CD8 T cells.
Conclusion
GO:0050852 (T cell receptor signaling pathway) is a cornerstone of adaptive immunity, with intricate molecular mechanisms that are dysregulated in cancer, autoimmunity, and immunodeficiency. Advances in CRISPR engineering and single-molecule imaging continue to reveal new layers of regulation, such as phase separation and post-translational modifications. Understanding this pathway is essential for developing next-generation immunotherapies and targeted treatments.
References
- 1. Shah K et al.. 2021. T cell receptor (TCR) signaling in health and disease.. Signal Transduct Target Ther 6(1):412 PMID: 34897277
- 2. Su X et al.. 2016. Phase separation of signaling molecules promotes T cell receptor signal transduction.. Science 352(6285):595-9 PMID: 27056844
- 3. Zhu X et al.. 2023. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell.. Gut Microbes 15(2):2249143 PMID: 37635362
- 4. Liu Y et al.. 2023. T-cell receptor signaling modulated by the co-receptors: Potential targets for stroke treatment.. Pharmacol Res 192:106797 PMID: 37211238
- 5. Fan Y et al.. 2020. Regulation of T cell receptor signaling by protein acyltransferase DHHC21.. Mol Biol Rep 47(8):6471-6478 PMID: 32789573
- 6. Warner K et al.. 2013. T-cell receptor signaling in peripheral T-cell lymphoma - a review of patterns of alterations in a central growth regulatory pathway.. Curr Hematol Malig Rep 8(3):163-72 PMID: 23892905
- 7. White WL et al.. 2025. Proofreading and single-molecule sensitivity in T cell receptor signaling by condensate nucleation.. Proc Natl Acad Sci U S A 122(22):e2422787122 PMID: 40445763
- 8. Weiss A. 2024. Peeking Into the Black Box of T Cell Receptor Signaling.. Annu Rev Immunol 42(1):1-20 PMID: 37788477
